BioNTech SE - ADR vs Noble Corporation plc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Noble Corporation plc trades at $44.25 (market cap $7.10B). The key difference: BioNTech SE - ADR is far larger — about 3.3× Noble Corporation plc's market cap, and Noble Corporation plc pays a 4.5% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | NE | |
|---|---|---|
Market Cap | $23.31B | $7.10B |
Sector | Health | Technology |
52-Week High | $119.34 | $54.37 |
52-Week Low | $83.89 | $26.61 |
Enterprise Value | $6.60B | $8.53B |
Dividend Yield | — | 4.5% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →